Filter
8703
Filtered Results: 8703
Text search:
key
diseases
Featured
Recommendations
767
New Publications
2284
Language
Document type
No document type
4714
Studies & Reports
1569
Guidelines
1055
Manuals
451
Strategic & Response Plan
350
Fact sheets
232
Training Material
140
Situation Updates
85
Resource Platforms
30
Infographics
28
Online Courses
28
Brochures
17
Dashboards/Maps
2
App
1
Videos
1
Countries / Regions
Global
388
India
349
Kenya
272
Sierra Leone
220
Ethiopia
200
Liberia
187
South Africa
184
Uganda
172
Nigeria
167
Western and Central Europe
159
Nepal
157
Malawi
136
Africa
131
Bangladesh
127
Rwanda
123
Latin America and the Carribbean
123
Myanmar / Burma
120
Zambia
118
Tanzania
114
Ghana
101
Syria
93
Congo, Democratic Republic of
86
Ukraine
81
Philippines
69
Namibia
68
Guinea
66
South–East Asia Region
66
South Sudan
65
Mozambique
63
Zimbabwe
60
Cambodia
56
Lesotho
54
West and Central Africa
54
Asia
54
Eastern Europe
52
East and Southern Africa
49
Haiti
47
Middle East and North Africa
47
Yemen
45
Senegal
44
Russia
43
Indonesia
36
Brazil
34
Botswana
33
Eastern Europe and Central Asia
33
Cameroon
30
Pakistan
30
Burkina Faso
29
Eswatini/ Swaziland
25
Afghanistan
23
Sudan
23
Venezuela
23
Somalia
22
Western Pacific Region
22
Germany
20
Thailand
20
Mali
19
Colombia
19
Benin
17
Madagascar
17
USA
15
Jordan
14
Central African Republic
14
Lebanon
13
Sri Lanka
13
Tajikistan
13
Vietnam
13
North America
13
Côte d’Ivoire / Ivory Coast
12
Laos
12
Georgia
12
Iraq
11
Peru
11
Moldova
11
China
10
Angola
10
North Macedonia
9
Chile
9
Albania
9
Niger
8
Chad
8
Papua New Guinea
8
Guinea-Bissau
7
Burundi
7
Palestine
7
Southern Africa
7
United Kingdom
7
Saudi Arabia
6
Turkey
6
Ecuador
6
Libya
6
Iran
6
Kyrgyzstan
6
Kazakhstan
6
Togo
5
Egypt
5
Gambia
5
Poland
5
Armenia
5
Timor Leste/ East Timor
5
Jamaica
5
Argentina
4
Hungary
4
Greece
4
Mexico
4
Paraguay
4
Romania
4
Turkmenistan
4
Tunisia
4
Malaysia
3
Serbia
3
El Salvador
3
Bolivia
3
Bhutan
3
Italy
3
Canada
3
Uzbekistan
3
Mauritius
3
Spain
3
Belarus
3
Morocco
2
Mauritania
2
Ireland
2
Vanuatu
2
Honduras
2
Fiji
2
North Korea
2
Djibouti
2
Mongolia
2
Qatar
2
Bulgaria
2
Slovakia
2
Gabon
2
Japan
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Singapore
1
Dominican Republic
1
Croatia
1
Guatemala
1
Cape Verde
1
Other region
1
Solomon Islands
1
Congo-Brazzaville
1
Estonia
1
Lithuania
1
Denmark
1
Belgium
1
France
1
Maldives
1
South Korea
1
Algeria
1
Morocco
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
3253
Clinical Guidelines
616
Public Health
540
Key Resources
409
Women & Child Health
384
Capacity Building
181
Pharmacy & Technologies
80
Annual Report MEDBOX
3
Toolboxes
COVID-19
923
HIV
715
Mental Health
566
TB
425
Planetary Health
355
Ebola
321
AMR
275
Rapid Response
273
Disability
239
Caregiver
232
NCDs
226
NTDs
216
Conflict
211
Global Health Education
154
Refugee
133
Natural Hazards
127
Pharmacy
123
Health Financing Toolbox
98
Cholera
73
Zika
65
Polio
50
Specific Hazards
43
Social Ethics
24
Typhoon
6
Health Financing
3
South Sudan
2
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentat...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients unde...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-p...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mo...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Int...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessmen...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region wa...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care w...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gap...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these c...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifesty...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its v...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional .... Despite prior perception of low NCDs mortality rates, current evidence suggests that SSA is now at the dawn of the epidemiological transition with contemporary double burden of disease from NCDs and communicable diseases. In SSA, cardiovascular diseases (CVDs) are the most frequent causes of NCDs deaths, responsible for approximately 13% of all deaths and 37% of all NCDs deaths. Although ischemic heart disease (IHD) has been identified as the leading cause of CVDs mortality in SSA followed by stroke and hypertensive heart disease from statistical models, real field data suggest IHD rates are still relatively low. The neglected endemic CVDs of SSA such as endomyocardial fibrosis and rheumatic heart disease as well as congenital heart diseases remain unconquered. While the underlying aetiology of heart failure among adults in high-income countries (HIC) is IHD, in SSA the leading causes are hypertensive heart disease, cardiomyopathy, rheumatic heart disease, and congenital heart diseases. Of concern is the tendency of CVDs to occur at younger ages in SSA populations, approximately two decades earlier compared to HIC. Obstacles hampering primary and secondary prevention of CVDs in SSA include insufficient health care systems and infrastructure, scarcity of cardiac professionals, skewed budget allocation and disproportionate prioritization away from NCDs, high cost of cardiac treatments and interventions coupled with rarity of health insurance systems. This review gives an overview of the descriptive epidemiology of CVDs in SSA, while contrasting with the HIC and highlighting impediments to their management and making recommendations.
